Benjamin Toll to Dopamine Uptake Inhibitors
This is a "connection" page, showing publications Benjamin Toll has written about Dopamine Uptake Inhibitors.
Connection Strength
0.595
-
Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trial. Psychol Addict Behav. 2007 Dec; 21(4):534-44.
Score: 0.269
-
A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain. Addict Behav. 2008 Jan; 33(1):173-9.
Score: 0.259
-
Message framing for smoking cessation: the interaction of risk perceptions and gender. Nicotine Tob Res. 2008 Jan; 10(1):195-200.
Score: 0.068